Last update 12 Apr 2025

ALF-1001

Overview

Basic Info

Drug Type
Recombinant protein
Synonyms
IFN alpha-14 (Alfacyte), ALF-1001
Target
IFNAR
Action
agonists
Mechanism
IFNAR agonists(Interferon alpha/beta receptor agonists)
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
Respiratory Syncytial Virus InfectionsCOVID-19
Inactive Indication
Psoriasis
Originator Organization
ILC Therapeutics Ltd.ILC Therapeutics Ltd.
Active Organization
ILC Therapeutics Ltd.ILC Therapeutics Ltd.
Inactive Organization-
Drug Highest PhaseClinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with ALF-1001
Login to view more data
100 Translational Medicine associated with ALF-1001
Login to view more data
100 Patents (Medical) associated with ALF-1001
Login to view more data
100 Deals associated with ALF-1001
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Respiratory Syncytial Virus InfectionsClinical
United Kingdom
ILC Therapeutics Ltd.ILC Therapeutics Ltd.
-
COVID-19Preclinical
United Kingdom
ILC Therapeutics Ltd.ILC Therapeutics Ltd.
09 Apr 2024
PsoriasisDiscovery
United Kingdom
ILC Therapeutics Ltd.ILC Therapeutics Ltd.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free